Sort
30,917 grants matching “tumor microenvironment”
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$1,588,248Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Prostate Cancer Bone Metastasis Biology and Targeting
$1,587,650Michael R Freeman · Cedars-Sinai Medical Center · P01 · FY2019 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,586,326Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Therapeutic Opportunities for Pediatric Astrocytoma
$1,583,141Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2015 · CA
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
$1,581,538Amato J. Giaccia · Stanford University · P01 · FY2007 · CA
exRNA released by glioblastoma alters brain microenvironment
$1,581,106Xandra Owens Breakefield · Massachusetts General Hospital · U19 · FY2016 · CA
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome
$1,579,708William M Grady · Fred Hutchinson Cancer Center · U54 · FY2025 · CA
Growth Factor Imaging and Photoimmunotherapy
$1,578,593Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
The Effects Of CAM Biological Agents In Human Prostate Cells In Vitro
$1,578,000Julia T Arnold · National Center For Complementary & Integrative Health · ZIA · FY2009 · AT
Molecular diagnosis and outcome prediction in lymphoma
$1,577,900Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Photodynamic therapy for neoplastic diseases involving serosal surfaces
$1,577,126Eli J Glatstein · University Of Pennsylvania · P01 · FY2011 · CA
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome
$1,577,081William M Grady · Fred Hutchinson Cancer Center · U54 · FY2024 · CA
Mechanisms of Esophageal Carcinogenesis
$1,576,087Anil K Rustgi · Columbia University Health Sciences · P01 · FY2020 · CA
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
$1,575,472Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2020 · HL
Differential activation of the triacylglycerol pathway in lipofibroblasts induces neurogenesis associated with prostate cancer progression
$1,575,170Omar Franco Coronel · Louisiana State Univ Hsc Shreveport · R01 · FY2025 · CA
Functional Biology Of T Cells
$1,574,498Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Genetic Analysis of the Breast Tumor Microenvironment
$1,574,165Michael C Ostrowski · Ohio State University · P01 · FY2012 · CA
Mechanisms of Esophageal Carcinogenesis
$1,573,148Anil K Rustgi · Columbia University Health Sciences · P01 · FY2021 · CA
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma
$1,571,990John Peter Wikswo · Vanderbilt University · U01 · FY2018 · TR
CD28-KITv CAR T cells with PD-1 dominant negative receptor
$1,570,342Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · UG3 · FY2025 · CA
Mechanisms of Esophageal Carcinogenesis
$1,569,941Anil K Rustgi · Columbia University Health Sciences · P01 · FY2023 · CA
Modulating BBB Permeability in Malignant Glioma
$1,568,447Sadhana Jackson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
The Biology of Prostate Cancer Skeletal Metastases
$1,568,348Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2010 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,566,117Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL).
$1,565,481David G Brooks · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2024 · CA